SEC Tracker
Get the app

Latigo Biotherapeutics LTGO

Foresite Capital Fund VI reports a 3.5% stake in Latigo Biotherapeutics

Form
Schedule 13D
Filed
Importance
Notable

Not explained yet; the original is on EDGAR.

Ownership stake disclosure by Foresite Capital Fund VI LP

View on EDGAR

Open in the app

Get an email when Latigo Biotherapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float not reported.

  1. Acura Pharmaceuticals ACUR
  2. Ayala Pharmaceuticals ADXS
  3. Ampio Pharmaceuticals AMPE
  4. Alterity Therapeutics ATHE
  5. Adhera Therapeutics ATRX